Kalaris Therapeutics Statistics
NASDAQ: KLRSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.56-0.10 (-3.76%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Kalaris Therapeutics by the numbers
Kalaris Therapeutics has a market capitalization of $60.9 million based on 23.80M shares outstanding. With trailing EPS of $-2.02, Kalaris Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.6% below its 50-day average and 57.3% below its 200-day average.
Average daily trading volume is 251.42K shares, or about $643,630 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KLRS valuation vs. peer median
| Metric | KLRS | Peer median | Difference |
|---|---|---|---|
| Market cap | $60.94M | $56.60M | +8% |
| Avg. volume | 251.42K | 30.54K | +723% |
Peer median across 8 companies: ELOX, INKT, CRBU, LONA, BKHA, CSBR, IMA, INMB.
Valuation
- Market cap
- $60.94M
- EPS (TTM)
- $-2.02
- Shares outstanding
- 23.80M
Price and trading
- Previous close
- 2.66
- Open
- 2.59
- Day range
- 2.53 – 2.69
- 52-week range
- 2.51 – 11.88
- 52-week change
- -66.84%
- Beta
- —
- Volume
- 74.12K
- Average volume
- 251.42K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 7, 2025
Additional statistics
- Market Cap
- 60.94M
- Forward Pe
- -1.54
- Eps
- -2.02
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.88
- Week52 Low
- 2.51
- Avg Volume
- 251.42K
- Shares Outstanding
- 23.80M
- Ma50
- 3.59
- Ma200
- 5.99
- Earnings Date
- Aug 7, 2025
- Pct From52w High
- -78.45%
- Pct From52w Low
- 1.99%